Table 2

Comparison between the normal ABI group (ABI⩾1.00) and the low ABI group (ABI<1.00)

Group studySLESLE + aCL/LASLE+APS
TotalABI⩾1ABI<1pABI⩾1ABI<1pABI⩾1ABI<1pABI⩾1ABI<1p
Number915734422411842
Age, mean (SD)39.0 (9.2)37.25 (8.78)41.91 (9.26)0.0237.10 (9.04)39.21 (9.24)NS39.82 (7.31)47.0 (5.18)0.0331.75 (9.0)54.0 (1.41)0.03
BMI, mean (SD)25.06 (5.46)25.22 (5.32)24.79 (5.74)NS25.32 (5.53)24.04 (5.93)NS24.36 (3.23)26.79 (5.49)NS26.5 (8.46)25.75 (4.6)NS
ECLAM score, mean (SD)2.36 (1.52)2.57 (1.54)2.0 (1.43)NS2.48 (1.45)2.23 (1.29)NS2.68 (1.72)1.44 (1.7)NS3.25 (2.22)1.5 (2.12)NS
Duration of disease (years), mean (SD)9.0 (7.5)7.97 (6.36)10.9 (8.74)NS7.7 (6.19)9.25 (6.66)NS8.09 (6.09)14.81 (11.26)NS10.5 (9.95)15.0 (19.8)NS
Sex (female, male)86, 553, 433, 1NS40, 224, 0NS9, 27, 1NS4, 02, 0
Race (white, black, oriental-Asian, Indian-Asian)59, 22, 7, 337, 12, 7, 122, 10, 0, 2NS28, 9, 4, 113, 9, 0, 1NS6, 3, 2, 07, 1, 0, 1NS3, 0, 1, 02, 0, 0, 0NS
Obesity (%)38.540.435.3NS47.629.2NS18.250NS
Smoking (%)23.128.114.7NS31.016.7NS18.212.5NS
Arterial hypertension (%)24.229.814.7NS21.412.5NS45.525NS
Diabetes (%)5.55.35.9NS4.84.2NS9.10NS
Hypothyroidism (%)9.98.811.8NS9.58.3NS9.112.5NS
Hyperlipidaemia (%)24.219.333.3NS19.025NS18.250NS
Nephrotic syndrome (%)19.826.38.80.0423.812.5NS27.30NS
Family history positive (%)35.229.844.1NS35.750NS18.237.5NS
Raynaud’s phenomenon (%)50.550.950.0NS57.254.2NS45.537.5NS
Arterial thrombosis (%)5.57.02.9NS7.10NS
Venous thrombosis (%)16.515.817.6NS11.912.5NS
MI (%)1.11.80NS2.40NS
Stroke (%)4.45.32.9NS4.80NS
Thrombosis (%)18.719.317.6NS16.712.5NS
Steroid treatment (years), mean (SD)3.73 (4.49)3.96 (4.62)3.34 (4.31)NS4.19 (4.82)3.48 (4.18)NS3.36 (3.38)3.5 (5.35)NS3.25 (5.25)1.0 (0)NS
Multivariate analysis
    Age0.03
    Nephrotic syndromeNS